Table 5.
The methodological quality of the reviewed studies using the PEDro scale.
Scales | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Authors | #1 | #2 | #3 | #4 | #5 | #6 | #7 | #8 | #9 | #10 | #11 | Total |
Zhu et al. [13] | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 7 |
Fungwe et al. [12] | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 5 |
Damirchi et al. [11] | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 5 |
QI et al. [30] | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 5 |
Xia et al. [31] | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 7 |
Brinke et al. [29] | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 7 |
Baker et al. [17] | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 6 |
Allard et al. [26] | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 7 |
Tarumi et al. [28] | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 6 |
Thomas et al. [33] | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 7 |
Amjad et al. [32] | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 5 |
Kohanpour et al. [27] | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 4 |
#1: Eligibility criteria (not included in the total score); #2: Random allocation; #3: Allocation was concealed; #4: The groups were similar in important criteria at the baseline; #5: Blind all subjects; #6: Blind therapy administration; #7: Blind all assessors; #8: Outcomes were obtained from more than 85%; #9: Intention to treat analysis; #10: Statistical comparisons between groups for at least one key factor; #11: Point estimates and variability.